Alcohol detoxification and relapse prevention using valproic acid versus gabapentin in alcohol-dependent patients

Addictive Disorders and their Treatment

Volumn 7, Issue 3, 2008, Pages 119-128

  Trevisan, Louis A ^a,b   Ralevski, Elizabeth ^a   Keegan, Kathryn ^a   Oville, Alison ^a   Vuppalapati, Dwarakanth ^a   Gonzalez, Gerardo ^a   Limoncelli, Diana ^a   Petrakis, Ismene L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Alcohol dependence; Alcohol detoxification; Gabapentin; Valproic acid

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE; GABAPENTIN; LORAZEPAM; PLACEBO; VALPROIC ACID;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANGER; ANOREXIA; ARTHRALGIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DETOXIFICATION; DIARRHEA; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG TOLERABILITY; EVENING DOSAGE; FATIGUE; FEMALE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL STRESS; MORNING DOSAGE; MYALGIA; NERVOUSNESS; NIGHT SWEAT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; RHINORRHEA; SIDE EFFECT; SLEEP DISORDER; SWEATING; TREATMENT OUTCOME;

EID: 67649998219     PISSN: 15315754     EISSN: None     Source Type: Journal    
DOI: 10.1097/ADT.0b013e31812e6a3c     Document Type: Article

References (39)

1. Trevisan L, Boutros N, Petrakis I, et al. Complications of alcohol withdrawal: pathophysiological insights. Alcohol Health Res World. 1998;22:61-66.
2. Kosten T,O'Connor P. Current concepts-management of drug withdrawal. N Engl J Med. 2003;348: 1786-1795.
3. Mayo-Smith MF. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal [see comment]. JAMA. 1997;278:144-151.
4. Book SW, Myrick H. Novel anticonvulsants in the treatment of alcoholism. Expert Opinion Invest Drugs. 2005;14:371-376.
5. Malcolm RJ. GABA systems, benzodiazepines, and substance dependence. J Clin Psychiatry. 2003;3: 36-40.
6. Brown ME, Anton RF, Malcolm R, et al. Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis. Biol Psychiatry. 1988;23:507-514.
7. Becker HC. The alcohol withdrawal "kindling" phenomenon: clinical and experimental findings. Alcohol: Clin Exp Res. 1996;20:121A-124A.
8. Malcolm R, Myrick H, Roberts JS, et al. The effects of lorazepam and carbamazepine on single vs. multiple previous alcohol withdrawals in an outpatient randomized trial. Alcohol: Clin Exp Res. 2000;24:38A.
9. Booth BM, Blow FC. The kindling hypothesis: further evidence from a U.S. national study of alcoholic men. Alcohol Alcohol. 1993;28:593-598.
10. Becker HC, Veatch LM, Diaz-Granados JL. Repeated ethanol withdrawal experience selectively alters sensitivity to different chemoconvulsant drugs in mice. Psychopharmacology. 1998;139:145-153.
11. Myrick H, Malcolm R, Brady KT. Gabapentin treatment of alcohol withdrawal [see comment]. Am J Psychiatry. 1998;11:1432.
12. Rosenthal RN, Perkel C, Singh P, et al. A pilot open randomized trial of valproate and phenobarbital in the treatment of acute alcohol withdrawal. Am J Addict. 1998;7:189-197.
13. Reoux JP, Saxon AJ, Malte CA, et al. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial. Alcohol: Clin Exp Res. 2001;25:1324-1329.
14. Lambie DG, Johnson RH, Vijayasenan ME, et al. Sodium valproate in the treatment of the alcohol withdrawal syndrome. Aust N Z J Psychiatry. 1980; 14:213-215.
15. Longo LP, Campbell T, Hubatch S. Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention. J Addict Dis. 2002;21:55-64.
16. Lum E, Gorman SK, Slavik RS. Valproic acid management of acute alcohol withdrawal. Ann Phar-macother. 2006;40:441-448.
17. Voris J, Smith NL, Rao SM, et al. Gabapentin for the treatment of ethanol withdrawal. Subst Abuse. 2003;24:129-132.
18. Tran KT, Hranicky D, Lark T, et al. Gabapentin withdrawal syndrome in the presence of a taper. Bipolar Disord. 2005;7:302-304.
19. Bonnet U, Banger M, Leweke FM, et al. Treatment of acute alcohol withdrawal with gabapentin: results from a controlled two-center trial. J Clin Psychopharmacol. 2003;23:514-519.
20. Mariani JJ, Rosenthal RN, Tross S, et al. A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal. Am J Addict. 2006;15:76-84.
21. Satel SL, Kosten TR, Schuckit MA, et al. Should protracted withdrawal from drugs be included in DSM-IV? [see comment]. Am J Psychiatry. 1993;150:695-704.
22. Anton RF. Pharmacologic approaches to the management of alcoholism. J Clin Psychiatry. 2001; 20:11-17.
23. Spitzer RL, Williams JB, Gibbon M, et al. The Structured Clinical Interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry. 1992;49:624-629.
24. Sobell LC, Sobell MB. Timeline Follow-Back: a technique for assessing self-reported alcohol consumption. In: Litten RZ, Allen J, eds. Measuring Alcohol Consumption: Psychosoical and Biological Methods. Totowa, NJ: Humana Press; 1992: 41-72.
25. Anton RF, Moak DH, Latham PK. The Obsessive Compulsive Drinking Scale: a new method of assessing outcome in alcoholism treatment studies [published erratum appears in Arch Gen Psychiatry. 1996;53:576]. Arch Gen Psychiatry. 1996;53: 225-231.
26. McNair D, Lorr M, Droppleman L. EITS Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Services; 1971.
27. Buysse DJ, Reynolds CF III, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193-213.
28. Hedeker D, Gibbons R, Davis J. Random regression models for multicenter clinical trials data. Psycho-pharmacol Bull. 1991;27:73-77.
29. Anton RF, Moak DH, Latham P. The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol: Clin Exp Res. 1995; 19:92-99.
30. Naranjo CA, Sellers EM, Chater K, et al. Nonphar-macologic intervention in acute alcohol withdrawal. Clin Pharmacol Ther. 1983;34:214-219.
31. Brady K, Myrick H, Henderson S, et al. The use of divalproex in alcohol relapse prevention: a pilot study. Drug Alcohol Dependence. 2002;67:323-330.
32. Salloum IM, Cornelius JR, Daley DC, et al. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry. 2005;62:37-45.
33. Karam-Hage M, Brower KJ. Open pilot study of gabapentin Versus trazodone to treat insomnia in alcoholic outpatients. Psychiatry Clin Neurosci. 2003;57:542-544.
34. Karam-Hage M, Bower K. Gabapentin treatment for insomnia associated with alcohol dependence. Am J Psychiatry. 2000;157:151.
35. Johnson BA. Uses of topiramate in the treatment of alcohol dependence. Expert Rev Neurother. 2004;4:751-758.
36. Johnson BA. Progress in the development of topi-ramate for treating alcohol dependence: from a hypothesis to a proof-of-concept study. Alcohol: Clin Exp Res. 2004;28:1137-1144.
37. Asnis GM, Kohn SR, Henderson M, et al. SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations. Drugs. 2004;64:383-404.
38. Van Ameringen M, Mancini C, Pipe B, et al. Antiepileptic drugs in the treatment of anxiety disorders: role in therapy. Drugs. 2004;64: 2199-2220.
39. Lum M, Fontaine R, Elie R, et al. Divalproex sodium's antipanic effects in panic disorder: a placebo-controlled study. Biol Psychiatry. 1990;27:164A.